S&P/ASX All Ordinaries Index (ASX: XAO) shares continue to surge in November, with three stocks nudged over 10% in Wednesday's session.
EML Payments Ltd (ASX: EML), Web Travel Group Ltd (ASX: WEB), and BrainChip Holdings Ltd (ASX: BRN) have each passed this mark today.
At the time of writing, EML Payments is up 11% to 97.5 cents, Web Travel has surged 14% to $4.80, and BrainChip has climbed 11% to 26.8 cents.
Let's dive into what's driving the action behind these movers.
EML Payments has been clawing back investor confidence after a turbulent period. The company's latest trading update posted yesterday showed revenue climbing 12% to nearly $49 million, underlined by a 46% jump in pre-tax earnings.
Management also reaffirmed its guidance of $54 million to $60 million in pre-tax earnings for FY25, underpinned by a medium-term plan to drive transaction revenue growth into double digits by FY27.
RBC Capital Markets is bullish on the stock and retained its buy rating in a note to clients today.
The broker values the ASX All Ords share at $1.20 apiece, noting the upsides from EML's trading update and the impact this has on its stock price.
Management also has the audacious goal of earning 13 cents per share at the bottom line by FY28.
Web Travel has also had an exceptional day, with its shares rocketing 14% following the release of its first-half results.
The company reported a 25% increase in total transaction value, tallying $2.6 billion, alongside a 23% surge in bookings.
This came even as revenue growth saw a modest growth of just 1%, as weaker margins offset these gains.
Managing director John Guscic admitted that margins in Europe had been negatively affected by seasonal disruptions, but he expressed confidence in a recovery for FY26.
He forecast pre-tax earnings of $117 million to $122 million for this coming financial year. Guscic also praised the WebBeds segment, saying it is "one of the fastest organically growing travel brands".
Investors seem to have embraced this forward-looking view, driving the ASX All Ords share to its highest mark since October 14.
BrainChip has been a volatile ASX All Ords share in recent months, but investors have bid up the share more than 11% today despite no price-sensitive news.
BrainChip's quarterly update earlier this month offered some positive indicators. The company reported a strengthened cash position of US$25.6 million following a $25 million capital raise.
The artificial intelligence (AI) company also secured partnerships with Frontgrade Gaisler and Airbus Defence and Space, expanding the adoption of its Akida 1.0 technology in the aerospace domain.
These agreements could represent a meaningful revenue opportunity if executed well.
Zooming out, the stock is up more than 16% in the past week of trade, alongside a snapback rally in broad tech.
The S&P/ASX All Technology Index (ASX: XTX) is also up less than 1% today, having climbed more than 2% since last Friday.
All three of these ASX All Ords shares face unique challenges and opportunities, but investors have bid up their prices today.
Where they go from here depends on many factors. In the last 12 months, Brainchip is up 21%, whereas EML and Web Travel are down 11% and 17%, respectively.
The post 3 ASX All Ords shares rocketing over 10% today appeared first on The Motley Fool Australia.
Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended EML Payments. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2024